Blog

Validating Complex Traits in Polyploid Crops: PACE® Genotyping in Rose GWAS Research

Validating Complex Traits in Polyploid Crops: PACE® Genotyping in Rose GWAS Research

A recent study led by researchers at the Institute of Plant Genetics, Department of Molecular Plant Breeding, Leibnez University Hannover, Germany demonstrates how PACE® genotyping can be used to robustly validate marker–trait associations in genetically complex, polyploid crops such as ornamental roses.

Modern plant breeding increasingly relies on molecular markers to reduce time, cost and uncertainty, particularly when working with genetically complex, polyploid species. A recent study published in Frontiers in Plant Science demonstrates how PACE® genotyping technology can play a critical role in validating marker–trait associations identified through genome-wide association studies (GWAS) in ornamental roses.

The challenge: breeding precision in polyploid roses

Roses are among the world’s most economically important ornamental crops, but their genetics present a significant challenge to breeders. Most cultivated roses are autotetraploid, meaning they carry four copies of each chromosome. This genetic complexity complicates both trait inheritance and marker analysis, particularly for quantitative traits such as:

  • Flower fragrance
  • Petal number and length
  • Leaf glossiness
  • Prickle density
  • Anthocyanin coloration

While GWAS has become a powerful discovery tool, independent marker validation remains essential, especially when associations are intended for marker-assisted selection (MAS) in breeding programmes.

The study: GWAS followed by independent PACE® validation

In the study “Beyond bloom: validated marker–trait discovery for polyploid roses via GWAS”, researchers analysed 285 rose cultivars using a high-density SNP array and identified significant marker–trait associations across nine ornamental traits

Crucially, the team then moved beyond discovery by validating selected SNP markers in independent rose panels (up to 190 additional genotypes) using PACE allele-specific PCR assays. This two-step approach ensured that marker effects were:

  • Suitable for practical breeding applications
  • Reproducible across environments
  • Detectable in new genetic backgrounds

Why PACE was chosen for validation

PACE genotyping was used as an alternative marker technology to SNP arrays for single-marker validation. In the paper, the authors highlight several practical advantages:

  • Robust allele-specific detection suitable for polyploid dosage analysis
  • Cost-effective genotyping, enabling larger validation panels
  • High-throughput compatibility using standard real-time PCR platforms
  • Flexibility to test multiple markers without probe redesign

Using PACE, the researchers successfully validated 26 SNP markers across six key ornamental traits of high commercial relevance to rose breeders, including flower fragrance, petal number, petal length and leaf glossiness.

Demonstrating marker robustness across traits

The study showed particularly strong validation outcomes for:

  • Flower number of petals, where several newly developed markers outperformed previously published reference markers
  • Flower fragrance, where multiple loci showed consistent, moderate-to-large effect sizes across panels
  • Leaf glossiness, where PACE-validated markers showed even stronger effects in the validation population than in the original GWAS

These results underline the value of PACE as a reliable downstream validation tool, supporting confident translation of GWAS discoveries into breeding decisions.

From discovery to application: supporting marker-assisted selection

Importantly, the authors note that their PACE-based validation strategy supports the robustness of marker–trait associations despite limited panel sizes, a common constraint in specialty crops and ornamentals

This reinforces a broader point for plant breeders and geneticists:

  • GWAS discoveries only become useful when markers can be validated, deployed and trusted in real breeding populations.
  • PACE enables exactly this transition, from discovery science to applied breeding, without the cost or complexity barriers often associated with probe-based genotyping methods

Making science affordable without compromising quality

This study exemplifies how affordable, flexible genotyping chemistry can support high-quality research in complex genomes. By using PACE for independent marker validation, the researchers were able to expand their analyses, strengthen confidence in their findings and deliver markers with genuine breeding value.

Ready to accelerate your trait discovery and validation?

If you are working to identify, validate, or deploy genetic markers for complex traits, whether in ornamentals, crops or other polyploid species, 3CR can help.

PACE genotyping provides a cost-effective, flexible, and scalable route from marker discovery to practical application, supporting everything from GWAS validation and trait confirmation through to marker-assisted selection in breeding programmes.

Our team works closely with researchers and breeders to:

  • Convert SNPs into robust PACE assays
  • Validate markers in independent populations
  • Scale genotyping without the cost or constraints of probe-based systems

If you’d like to explore how PACE could support your research or breeding goals, we’d be happy to discuss your project.

Contact 3CR to talk to our team about how PACE can help advance your research.

MORE POSTS

High-Throughput Screening of Gene Edits Using PACE Allele Specific Genotyping for Agriculture and Life Sciences
Discover how PACE® genotyping transforms CRISPR edit screening into a fast, scalable, and cost-effective workflow for agriculture and life sciences.
Transforming Genotyping Workflows with PACE® Multiplex Master Mix
Generate twice the SNP genotyping data in a single reaction while cutting DNA usage and costs in half.
PCR Steps in PACE High-Throughput Genotyping: From Sample Preparation to Fluorescence Detection
A practical walkthrough of PCR steps in PACE® genotyping, from sample prep to fluorescence readout.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR. 

Sign up now to receive insights, updates 
and industry case studies. 

This field is for validation purposes and should be left unchanged.
Name(Required)

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.